News | Treatment Planning | May 10, 2016

MIM Maestro software suite offers advanced tools for image fusion, contouring, deformable registration and automation

May 10, 2016 — MIM Software Inc. announced that GenesisCare Australia has selected MIM Maestro as their radiotherapy contouring and deformable registration solutions platform across the Genesis Cancer Care Network in Australia.

Genesis Cancer Care is the largest provider of radiotherapy in Australia, performing over 300,000 yearly radiation oncology treatments from its network of 27 sites across the region. An extensive evaluation led to MIM Software being selected as the preferred suite of products to address the increasing demands of complex treatment protocols, resource-intensive workflows and high patient volumes.

"We are very excited to be partnering with MIM Software," explained Keith Hansen, national executive manager at Genesis Cancer Care. "A great deal of time and effort was spent in evaluating an optimal solution that would allow us to incorporate advanced processes and technologies into our patient care workflows. We are continuously striving to provide high-quality care for patients, with clinical excellence in image management and treatment planning, a key outcome required of the partnership. By implementing MIM into our clinics we will ensure every patient in our care receives highly personalised and highly targeted treatments."

MIM Maestro is a medical software suite capable of solving complex problems through the use of advanced tools for image fusion, contouring, deformable registration and automation to enhance radiation therapy plans.

For more information: www.mimsoftware.com


Related Content

News | Radiation Oncology

May 2, 2025 — GE HealthCare has announced an intended expansion of its radiation oncology portfolio as well as the ...

Time May 03, 2025
arrow
News | Radiology Education

April 21, 2025 — On June 20, the American Society of Radiologic Technologists (ASRT) will award Life Member status to ...

Time April 21, 2025
arrow
News | Radiology Business

April 16, 2025 — According to a new report, the U.S. Radiotherapy Market is projected to reach $2.49 billion by 2030 ...

Time April 17, 2025
arrow
News | ASTRO

March 14, 2025 — Another pivotal milestone in the nation’s fight against cancer recently took place with the ...

Time March 17, 2025
arrow
News | Computed Tomography (CT)

Royal Philips recently received 510(k) clearance from the US Food and Drug Administration (FDA) for its detector-based ...

Time November 13, 2024
arrow
News

Aug. 5, 2024 — Researchers from The University of Texas MD Anderson Cancer Center have demonstrated that adding ...

Time August 09, 2024
arrow
News | PET-CT

July 31, 2024 — In a head-to-head comparison with FDG PET/CT, FDG PET/MRI demonstrated comparable or superior diagnostic ...

Time July 31, 2024
arrow
Feature | Radiation Oncology | By Christine Book

News emerging from several leading organizations and vendors in the radiation therapy arena came in at a fast pace in ...

Time July 30, 2024
arrow
News | Radiation Oncology

July 11, 2024 — The American Society for Radiation Oncology (ASTRO) issued the following statement from Jeff M ...

Time July 11, 2024
arrow
News | Radiation Oncology

July 9, 2024 — Insights from the latest Mordor Intelligence report, “Radiotherapy Market Size & Share Analysis - Growth ...

Time July 09, 2024
arrow
Subscribe Now